|
Aug 7
|
Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics
|
|
Aug 7
|
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 7
|
Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
|
|
Aug 6
|
Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates
|
|
Jul 24
|
Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025
|
|
Jun 24
|
Sight Sciences Leads The Pack Of 3 Promising Penny Stocks
|
|
Feb 13
|
Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day
|
|
Sep 30
|
Institutional investors own a significant stake of 34% in Sight Sciences, Inc. (NASDAQ:SGHT)
|
|
Jul 25
|
Integer (ITGR) Q2 Earnings Surpass Estimates
|
|
Jun 14
|
One Sight Sciences Insider Raised Stake By 34% In Previous Year
|
|
May 7
|
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
|
|
May 6
|
Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2024 Earnings Call Transcript
|
|
May 4
|
Sight Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 3
|
Q1 2024 Sight Sciences Inc Earnings Call
|
|
May 2
|
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance
|
|
Apr 30
|
Sight Sciences awarded $34m in Alcon patent infringement case
|
|
Apr 29
|
Sector Update: Health Care Stocks Edge Higher Late Afternoon
|
|
Apr 29
|
Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
|
|
Apr 22
|
With 34% ownership, Sight Sciences, Inc. (NASDAQ:SGHT) has piqued the interest of institutional investors
|